Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 585A (ZNF585A) is a member of the Krüppel C2H2-type zinc finger protein family, which is one of the largest superfamilies of DNA-binding proteins in eukaryotes[1][2]. ZNF585A acts as a predicted DNA-binding transcription activator with specificity for RNA polymerase II and is believed to be involved in the regulation of transcription[1]. It is primarily located in the nucleus[1]. ZNF585A has been associated with Ehlers-Danlos Syndrome, musculocontractural type, 1, but its roles in other diseases and biological processes are not well characterized[1]. There are currently no known drugs directly targeting ZNF585A, nor have specific biomarkers or safety concerns been described in the available literature. Alternative names include FLJ23765 and Zfp27[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 585A (ZNF585A).